cetuximab

You have access
Multicenter Phase II Study of Second-line Cetuximab plus Folinic Acid/5-Fluorouracil/Irinotecan (FOLFIRI) in KRAS Wild-type Metastatic Colorectal Cancer: The FLIER Study
SHIGEYOSHI IWAMOTO, SHOICHI HAZAMA, TAKESHI KATO, YASUHIRO MIYAKE, MUTSUMI FUKUNAGA, CHU MATSUDA, HIROYUKI BANDO, JUNICHI SAKAMOTO, KOJI OBA and HIDEYUKI MISHIMA

Anticancer Research April 2014, 34 (4) 1967-1973;
You have access
Chemoembolization in Colorectal Liver Metastases: The Rebirth
GIAMMARIA FIORENTINI, CAMILLO ALIBERTI, LUCA MULAZZANI, PAOLO COSCHIERA, VINCENZO CATALANO, DAVID ROSSI, PAOLO GIORDANI and STEFANO RICCI

Anticancer Research February 2014, 34 (2) 575-584;
You have access
Epidermal Growth Factor Receptor (EGFR)-targeted Therapies in Esophagogastric Cancer
SABARISH AYYAPPAN, DHIVYA PRABHAKAR and NEELESH SHARMA

Anticancer Research October 2013, 33 (10) 4139-4155;
You have access
Radiation-induced Dimer Formation of EGFR: Implications for the Radiosensitizing Effect of Cetuximab
MAKOTO KIYOZUKA, TETSUO AKIMOTO, MIKA FUKUTOME, ATSUSHI MOTEGI and NORIO MITSUHASHI

Anticancer Research October 2013, 33 (10) 4337-4346;
You have access
Circulating Tumor Cell (CTC) Count and Epithelial Growth Factor Receptor Expression on CTCs as Biomarkers for Cetuximab Efficacy in Advanced Colorectal Cancer
YASUTOSHI KUBOKI, SATOSHI MATSUSAKA, SAYURI MINOWA, HARUMI SHIBATA, MITSUKUNI SUENAGA, EIJI SHINOZAKI, NOBUYUKI MIZUNUMA, MASASHI UENO, TOSHIHARU YAMAGUCHI and KIYOHIKO HATAKE

Anticancer Research September 2013, 33 (9) 3905-3910;
You have access
Antitumor Activity of Elacytarabine Combined with Bevacizumab, Cetuximab and Trastuzumab in Human NSCLC Xenografts
SKJALG BRUHEIM, MARIT LILAND SANDVOLD, GUNHILD M. MÆLANDSMO and ØYSTEIN FODSTAD

Anticancer Research September 2013, 33 (9) 3615-3621;
You have access
KRAS Mutations in Patients with Colorectal Cancer as Detected by High-resolution Melting Analysis and Direct Sequencing
KOHEI AKIYOSHI, YASUHIDE YAMADA, YOSHITAKA HONMA, SATORU IWASA, KEN KATO, TETSUYA HAMAGUCHI, YASUHIRO SHIMADA, HIROKAZU TANIGUCHI and KOH FURUTA

Anticancer Research May 2013, 33 (5) 2129-2134;

Main menu

User menu

Search

cetuximab

Pages